We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.36B
AUM Growth
-$1.68B
Cap. Flow
-$1.45B
Cap. Flow %
-43.28%
Top 10 Hldgs %
28.65%
Holding
6,080
New
399
Increased
1,937
Reduced
2,718
Closed
947

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$101M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$97.8M
4
MSFT icon
Microsoft
MSFT
+$89.5M
5
AMZN icon
Amazon
AMZN
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Financials 9.87%
3 Consumer Discretionary 8.34%
4 Healthcare 7.98%
5 Communication Services 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABAT icon
4001
American Battery Technology Co
ABAT
$340M
$6.88K ﹤0.01%
6,675
-23,098
-78% -$31.3K
ZYXI
4002
DELISTED
Zynex
ZYXI
$6.84K ﹤0.01%
3,110
-288
-8% -$1.88K
STVN icon
4003
Stevanato
STVN
$5.75B
$6.84K ﹤0.01%
335
-7,078
-95% -$151K
CELZ icon
4004
Creative Medical Technology
CELZ
$8.04M
$6.84K ﹤0.01%
3,152
+1,504
+91% +$5.25K
AXIL
4005
AXIL Brands
AXIL
$41.5M
$6.84K ﹤0.01%
1,368
+37
+3% +$242
GDHG icon
4006
Golden Heaven Group Holdings
GDHG
$79.7M
$6.83K ﹤0.01%
+4
New +$2.77K
VTVT icon
4007
vTv Therapeutics
VTVT
$119M
$6.82K ﹤0.01%
+394
New +$6.58K
HYPR icon
4008
Hyperfine
HYPR
$94.7M
$6.82K ﹤0.01%
9,525
+2,479
+35% +$2.55K
VSTD
4009
DELISTED
Vestand Inc
VSTD
$6.82K ﹤0.01%
2,224
-10,760
-83% -$24.6K
LIPO
4010
DELISTED
Lipella Pharmaceuticals
LIPO
$6.8K ﹤0.01%
+2,708
New +$7.87K
FPAY
4011
DELISTED
FlexShopper
FPAY
$6.79K ﹤0.01%
5,303
+783
+17% +$1.2K
YARW
4012
Yarrow Bioscience, Inc. Common Stock
YARW
$113M
$6.79K ﹤0.01%
86
+58
+207% +$7.14K
APRE icon
4013
Aprea Therapeutics
APRE
$8.42M
$6.79K ﹤0.01%
3,326
+1,848
+125% +$5.79K
VUZI icon
4014
Vuzix
VUZI
$258M
$6.78K ﹤0.01%
3,322
+2,668
+408% +$8.74K
PSLV icon
4015
Sprott Physical Silver Trust
PSLV
$13.4B
$6.76K ﹤0.01%
586
-14,673
-96% -$158K
AWF
4016
AllianceBernstein Global High Income Fund
AWF
$875M
$6.75K ﹤0.01%
629
+624
+12,480% +$6.76K
VRCA icon
4017
Verrica Pharmaceuticals
VRCA
$85.4M
$6.74K ﹤0.01%
1,524
+426
+39% +$2.75K
FEAM icon
4018
5E Advanced Materials
FEAM
$66.8M
$6.73K ﹤0.01%
1,757
+1,404
+398% +$10.3K
SGA icon
4019
Saga Communications
SGA
$62.1M
$6.71K ﹤0.01%
538
+203
+61% +$2.45K
XWEL icon
4020
XWELL
XWEL
$8.28M
$6.71K ﹤0.01%
6,574
+3,355
+104% +$3.9K
OR icon
4021
OR Royalties Inc
OR
$6.25B
$6.7K ﹤0.01%
317
-208
-40% -$4K
SOTK icon
4022
Sono-Tek
SOTK
$80.8M
$6.69K ﹤0.01%
1,838
+1,426
+346% +$5.47K
SLN
4023
Silence Therapeutics
SLN
$648M
$6.67K ﹤0.01%
2,367
+1,735
+275% +$8.47K
LYRA
4024
DELISTED
LYRA THERAPEUTICS INC
LYRA
$6.66K ﹤0.01%
1,055
+259
+33% +$2.42K
TTAN
4025
ServiceTitan Inc
TTAN
$8.62B
$6.66K ﹤0.01%
70
-812
-92% -$78.8K

Similar funds

Tower Research Capital (TRC)'s Q1 2025 Portfolio in Review

As of Q1 2025, Tower Research Capital (TRC) held 6,080 positions worth $3.36B, down 33% from $5.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.45B in Q1 2025, closing 947 positions and reducing 2,718 holdings. Its most notable exit was Listed Funds Trust Roundhill Magnificent Seven ETF, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $18.3M.

  • Tower Research Capital (TRC)'s largest Q1 2025 buy was Vanguard S&P 500 ETF: 35,404 shares worth $18.3M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2025, an estimated $274M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2025 reduction was Apple, cutting an estimated $126M.
  • Tower Research Capital (TRC) fully exited Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3.36B portfolio in Q1 2025.
  • Tower Research Capital (TRC) opened 399 new positions and closed 947 in Q1 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 33% quarter-over-quarter to $3.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.